Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6138145, 18 pages
https://doi.org/10.1155/2017/6138145
Review Article

The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression

Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

Correspondence should be addressed to János Kappelmayer; uh.bedinu.dem@reyamleppak

Received 2 February 2017; Revised 12 April 2017; Accepted 23 April 2017; Published 7 June 2017

Academic Editor: Marlien Pieters

Copyright © 2017 János Kappelmayer and Béla Nagy Jr. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. I. Johnston, R. G. Cook, and R. P. McEver, “Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation,” Cell, vol. 56, no. 6, pp. 1033–1044, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Ley, “The role of selectins in inflammation and disease,” Trends in Molecular Medicine, vol. 9, no. 6, pp. 263–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. McEver and M. N. Martin, “A monoclonal antibody to a membrane glycoprotein binds only to activated platelets,” Journal of Biological Chemistry, vol. 259, no. 15, pp. 9799–9804, 1984. View at Google Scholar · View at Scopus
  4. P. E. Stenberg, R. P. McEver, M. A. Shuman, Y. V. Jacques, and D. F. Bainton, “A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation,” Journal of Cell Biology, vol. 101, no. 3, pp. 880–886, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-C. Hsu-Lin, C. L. Berman, B. C. Furie, D. August, and B. Furie, “A platelet membrane protein expressed during platelet activation and secretion,” Journal of Biological Chemistry, vol. 259, no. 14, pp. 9121–9126, 1984. View at Google Scholar
  6. E. Larsen, A. Celi, G. E. Gilbert et al., “PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes,” Cell, vol. 59, no. 2, pp. 305–312, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. McEver, J. H. Beckstead, K. L. Moore, L. Marshall-Carlson, and D. F. Bainton, “GMP-140, a platelet α–granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel–Palade bodies,” The Journal of Clinical Investigation, vol. 84, no. 1, pp. 92–99, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. Bevilacqua, S. Stengelin, M. A. Gimbrone Jr., and B. Seed, “Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins,” Science, vol. 243, no. 4895, pp. 1160–1165, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. W. M. Gallatin, I. L. Weissman, and E. C. Butcher, “A cell–urface molecule involved in organ–specific homing of lymphocytes,” Nature, vol. 304, no. 5921, pp. 30–34, 1983. View at Publisher · View at Google Scholar · View at Scopus
  10. T. F. Tedder, C. M. Isdaacs, T. J. Ernst, G. D. Demetri, D. A. Adler, and C. M. Disteche, “Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins,” Journal of Experimental Medicine, vol. 170, no. 1, pp. 123–133, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Au and E. C. Josefsson, “Regulation of platelet membrane protein shedding in health and disease,” Platelets, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  12. V. S. Dole, W. Bergmeier, I. S. Patten, J. Hirahashi, T. N. Mayadas, and D. D. Wagner, “PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets,” Thrombosis and Haemostasis, vol. 98, no. 4, pp. 806–812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Ishiwata, K. Takio, M. Katayama et al., “Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule,” Journal of Biological Chemistry, vol. 269, no. 38, pp. 23708–23715, 1994. View at Google Scholar · View at Scopus
  14. H. Setiadi, M. Disdier, S. A. Green, W. M. Canfield, and R. P. McEver, “Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 26818–26826, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Setiadi, G. Sedgewick, S. L. Erlandsen, and R. P. McEver, “Interactions of the cytoplasmic domain of P-selectin with clathrin- coated pits enhance leukocyte adhesion under flow,” Journal of Cell Biology, vol. 142, no. 3, pp. 859–871, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Hattori, K. K. Hamilton, R. D. Fugate, R. P. McEver, and P. J. Sims, “Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140,” Journal of Biological Chemistry, vol. 264, no. 14, pp. 7768–7771, 1989. View at Google Scholar · View at Scopus
  17. T. Schlüter, P. Knauth, S. Wald, S. Boland, and R. Bohnensack, “Numb3 is an endocytosis adaptor for the inflammatory marker P-selectin,” Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 909–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Setiadi and R. P. McEver, “Clustering endothelial E-selectin in clathrin-coated pits and lipid rafts enhances leukocyte adhesion under flow,” Blood, vol. 111, no. 4, pp. 1989–1998, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. Moore, A. Varki, and R. G. McEver, “GMP-140 binds to a glycoprotein receptor on human neutrophils: evidence for a lectin-like interaction,” Journal of Cell Biology, vol. 112, no. 3, pp. 491–499, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Vachino, X.-J. Chang, G. M. Veldman et al., “P-selectin glycoprotein ligand-1 is the major counter–receptor for P- selectin on stimulated T cells and is widely distributed in non–functional form on many lymphocytic cells,” Journal of Biological Chemistry, vol. 270, no. 37, pp. 21966–21974, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ushiyama, T. M. Laue, K. L. Moore, H. P. Erickson, and R. P. McEver, “Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin,” Journal of Biological Chemistry, vol. 268, no. 20, pp. 15229–15237, 1993. View at Google Scholar · View at Scopus
  22. Z. Laszik, P. J. Jansen, R. D. Cummings, T. F. Tedder, R. P. McEver, and K. L. Moore, “P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells,” Blood, vol. 88, no. 8, pp. 3010–3021, 1996. View at Google Scholar · View at Scopus
  23. B. Nagy Jr., K. Miszti-Blasius, A. Kerényi, K. J. Clemetson, and J. Kappelmayer, “Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation,” Current Medicinal Chemistry, vol. 19, no. 4, pp. 518–531, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Afshar-Kharghan, R. Diz-Küçükkaya, E. H. Ludwig, A. J. Marian, and J. A. López, “Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region,” Blood, vol. 97, no. 10, pp. 3306-3307, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Roldán, R. González-Conejero, F. Marín, J. Pineda, V. Vicente, and J. Corral, “Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction,” American Heart Journal, vol. 148, no. 4, pp. 602–605, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-M. Herrmann, S. Ricard, V. Nicaud et al., “The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction,” Human Molecular Genetics, vol. 7, no. 8, pp. 1277–1284, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. C. Barbaux, S. Blankenberg, H. J. Rupprecht et al., “Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 10, pp. 1668–1673, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Carter, K. Anagnostopoulou, M. W. Mansfield, and P. J. Grant, “Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease,” Journal of Thrombosis and Haemostasis, vol. 1, no. 8, pp. 1718–1723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Nagy Jr., E. Csongrádi, H. P. Bhattoa et al., “Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus,” Thrombosis and Haemostasis, vol. 98, no. 1, pp. 186–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Csongrádi, B. Nagy Jr., T. Fulop et al., “Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients,” Thrombosis and Haemostasis, vol. 106, no. 4, pp. 683–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Undas, W. Tracz, and Z. Siudak, “Thr715Pro P-selectin polymorphism and P-selectin release in blood obtained from the bleeding time wounds in patients with deep–vein thrombosis,” Thrombosis Research, vol. 124, no. 2, pp. 248–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. M. Revelle, D. Scott, and P. J. Beck, “Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity,” The Journal of Biological Chemistry, vol. 271, no. 27, pp. 16160–16170, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Wenzel, R. Stahn, A. Speer et al., “Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations,” Biological Chemistry, vol. 380, no. 6, pp. 661–667, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Berardi, N. B. Larson, P. A. Decker et al., “Multi-ethnic analysis reveals soluble l-selectin may be post-transcriptionally regulated by 3′UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA),” Human Genetics, vol. 134, no. 4, pp. 393–403, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Wang and X. Yan, “CD146, a multi-functional molecule beyond adhesion,” Cancer Letters, vol. 2, pp. 150–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. K. Wild, K. Lühn, T. Marquardt, and D. Vestweber, “Leukocyte adhesion deficiency II: therapy and genetic defect,” Cells Tissues Organs, vol. 172, no. 3, pp. 161–173, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Malý, A. D. Thall, B. Petryniak et al., “The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis,” Cell, vol. 86, no. 4, pp. 643–653, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Ramachandran, T. Yago, T. K. Epperson et al., “Dimerization of a selectin and its ligand stabilizes cell rolling and enhances tether strength in shear flow,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10166–10171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. J. J. Miner, L. Xia, T. Yago et al., “Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow,” Blood, vol. 112, no. 5, pp. 2035–2045, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Koenig, K. Norgard-Sumnicht, R. Linhardt, and A. Varki, “Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins: implications for the use of unfractionated and low molecular weight heparins as therapeutic agents,” Journal of Clinical Investigation, vol. 101, no. 4, pp. 877–889, 1998. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Wang, J. R. Brown, A. Varki, and J. D. Esko, “Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins,” Journal of Clinical Investigation, vol. 110, no. 1, pp. 127–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Takeishi, Y. Imai, S. Ishida, T. Omori, R. D. Kamm, and T. Ishikawa, “Cell adhesion during bullet motion in capillaries,” American Journal of Physiology–Heart and Circulatory Physiology, vol. 311, no. 2, pp. H395–H403, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Marki, J. D. Esko, A. R. Pries, and K. Ley, “Role of the endothelial surface layer in neutrophil recruitment,” Journal of Leukocyte Biology, vol. 98, no. 4, pp. 503–515, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Sreeramkumar, J. M. Adrover, I. Ballesteros et al., “Neutrophils scan for activated platelets to initiate inflammation,” Science, vol. 346, no. 6214, pp. 1234–1238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Zuchtriegel, B. Uhl, D. Puhr-Westerheide et al., “Platelets guide leukocytes to their sites of extravasation,” PLoS Biology, vol. 14, no. 5, Article ID e1002459, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Rossaint, K. Kühne, J. Skupski et al., “Directed transport of neutrophil–derived extracellular vesicles enables platelet–mediated innate immune response,” Nature Communications, vol. 7, p. 13464, 2016. View at Publisher · View at Google Scholar
  47. M. G. Posner, A. Upadhyay, A. A. Abubaker et al., “Extracellular fibrinogen–binding protein (Efb) from staphylococcus aureus inhibits the formation of platelet–leukocyte complexes,” Journal of Biological Chemistry, vol. 291, no. 6, pp. 2764–2776, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Kappelmayer, B. Nagy Jr., K. Miszti-Blasius, Z. Hevessy, and H. Setiadi, “The emerging value of P-selection as a disease marker,” Clinical Chemistry and Laboratory Medicine, vol. 42, no. 5, pp. 475–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. A. D. Michelson, M. R. Barnard, L. A. Krueger, C. R. Valeri, and M. I. Furman, “Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction,” Circulation, vol. 104, no. 13, pp. 1533–1537, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. A. D. Blann, G. Y. H. Lip, D. G. Beevers, and C. N. McCollum, “Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers,” Thrombosis and Haemostasis, vol. 77, no. 6, pp. 1077–1080, 1997. View at Google Scholar · View at Scopus
  51. R. Fijnheer, C. J. M. Frijns, J. Korteweg et al., “The origin of P-selectin as a circulating plasma protein,” Thrombosis and Haemostasis, vol. 77, no. 6, pp. 1081–1085, 1997. View at Google Scholar · View at Scopus
  52. Y. Chen, Y. Lin, H. Lin et al., “Regular plateletpheresis increased basal concentrations of soluble P-selectin in healthy donors: possible involvement of endothelial cell activation?” Clinica Chimica Acta, vol. 458, pp. 18–22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Miyabe, N. D. Kim, C. Miyabe, and A. D. Luster, “Studying neutrophil migration in vivo using adoptive cell transfer,” Methods in Molecular Biology, vol. 1407, pp. 179–194, 2016. View at Google Scholar
  54. T. Palabrica, R. Lobb, B. C. Furie et al., “Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets,” Nature, vol. 359, no. 6398, pp. 848–851, 1992. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Celi, G. Pellegrini, R. Lorenzet et al., “P-selectin induces the expression of tissue factor on monocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 19, pp. 8767–8771, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Furie and B. C. Furie, “Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation,” Trends in Molecular Medicine, vol. 10, no. 4, pp. 171–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Falati, Q. Liu, P. Gross et al., “Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin,” Journal of Experimental Medicine, vol. 197, no. 11, pp. 1585–1598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. E. Slotta, O. O. Braun, M. D. Menger, and H. Thorlacius, “Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162,” Platelets, vol. 20, no. 7, pp. 505–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. P. S. Frenette, C. V. Denis, L. Weiss et al., “P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo,” Journal of Experimental Medicine, vol. 191, no. 8, pp. 1413–1422, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. K. H. Kim, A. Barazia, and J. Cho, “Real–time imaging of heterotypic platelet–neutrophil interactions on the activated endothelium during vascular inflammation and thrombus formation in live mice,” Journal of visualized experiments, no. 74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. I. Del Conde, F. Nabi, R. Tonda, P. Thiagarajan, J. A. López, and N. S. Kleiman, “Effect of P-selectin on phosphatidylserine exposure and surface–dependent thrombin generation on monocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 5, pp. 1065–1070, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Del Conde, C. N. Shrimpton, P. Thiagarajan, and J. A. López, “Tissue–factor–bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation,” Blood, vol. 106, no. 5, pp. 1604–1611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J.-F. Théorêt, D. Yacoub, A. Hachem, M.-A. Gillis, and Y. Merhi, “P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation,” Thrombosis Research, vol. 128, no. 3, pp. 243–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. D. A. Steeber, P. Engel, A. S. Miller, M. P. Sheetz, and T. F. Tedder, “Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes,” Journal of Immunology, vol. 159, no. 2, pp. 952–963, 1997. View at Google Scholar · View at Scopus
  65. Y. Ozaki, T. Imanishi, I. Teraguchi et al., “Association between P-selectin glycoprotein ligand-1 and pathogenesis in acute coronary syndrome assessed by optical coherence tomography,” Atherosclerosis, vol. 233, no. 2, pp. 697–703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Miszti-Blasius, I. B. Debreceni, S. Felszeghy, B. Dezso, and J. Kappelmayer, “Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge,” Thrombosis Research, vol. 127, no. 3, pp. 228–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Wang, K. Kleiman, J. Wang, W. Luo, C. Guo, and D. T. Eitzman, “Deficiency of P-selectin glycoprotein ligand-1 is protective against the prothrombotic effects of interleukin-1β,” Journal of Thrombosis and Haemostasis, vol. 13, no. 12, pp. 2273–2276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Wang, J. S. Knight, J. B. Hodgin et al., “Psgl-1 deficiency is protective against stroke in a murine model of lupus,” Scientific Reports, vol. 6, 2016. View at Google Scholar
  69. I. Hrachovinová, B. Cambien, A. Hafezi-Moghadam et al., “Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A,” Nature Medicine, vol. 9, no. 8, pp. 1020–1025, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Hubert, R. Darbousset, L. Panicot-Dubois et al., “Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin,” Journal of Thrombosis and Haemostasis, vol. 12, no. 7, pp. 1170–1181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Läubli and L. Borsig, “Selectins promote tumor metastasis,” Seminars in Cancer Biology, vol. 20, no. 3, pp. 169–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. S. V. Glavey, D. Huynh, and M. R. Reagan, “The cancer glycome: carbohydrates as mediators of metastasis,” Blood Reviews, vol. 29, no. 4, pp. 269–279, 2015. View at Google Scholar
  73. R. Kannagi, M. Izawa, T. Koike, K. Miyazaki, and N. Kimura, “Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis,” Cancer Science, vol. 95, no. 5, pp. 377–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Ogawa, H. Inoue, and S. Koide, “Expression of alpha-1, 3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer,” Cancer Res, vol. 56, no. 2, pp. 325–329, 1996. View at Google Scholar
  75. A. Hoos, D. Protsyuk, and L. Borsig, “Metastatic growth progression caused by PSGL-1- Mediated recruitment of monocytes to metastatic sites,” Cancer Research, vol. 74, no. 3, pp. 695–704, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Mannori, O. Cecconi, K. Hanasaki et al., “Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin–type glycoproteins,” Cancer Research, vol. 55, no. 19, pp. 4425–4431, 1995. View at Google Scholar · View at Scopus
  77. S.-H. Chen, M. R. Dallas, E. M. Balzer, and K. Konstantopoulos, “Mucin 16 is a functional selectin ligand on pancreatic cancer cells,” FASEB Journal, vol. 26, no. 3, pp. 1349–1359, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Borsig, R. Wong, J. Feramisco, D. R. Nadeau, N. M. Varki, and A. Varki, “Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3352–3357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Gout, P.-L. Tremblay, and J. Huot, “Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis,” Clinical and Experimental Metastasis, vol. 25, no. 4, pp. 335–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Läubli and L. Borsig, “Selectins as mediators of lung metastasis,” Cancer Microenvironment, vol. 3, no. 1, pp. 97–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. G. F. Nash, L. F. Turner, M. F. Scully, and A. K. Kakkar, “Platelets and cancer,” Lancet Oncology, vol. 3, no. 7, pp. 425–430, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. R. N. Kaplan, R. D. Riba, S. Zacharoulis et al., “VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche,” Nature, vol. 438, no. 7069, pp. 820–827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru, “Tumour–mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis,” Nature Cell Biology, vol. 8, no. 12, pp. 1369–1375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Gakhar, V. N. Navarro, M. Jurish et al., “Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow,” PLoS ONE, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. S.-A. Kang, N. Hasan, A. P. Mann et al., “Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis,” Molecular Therapy, vol. 23, no. 6, pp. 1044–1054, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Shi, J. Zhang, X. Han et al., “Recruited monocytic myeloid–derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β–mediated increase in E-selectin expression,” International Journal of Cancer, vol. 140, no. 6, pp. 1370–1383, 2017. View at Publisher · View at Google Scholar
  87. H. Läubli, K.-S. Spanaus, and L. Borsig, “Selectin–mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes,” Blood, vol. 114, no. 20, pp. 4583–4591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Dong, M. J. Slattery, S. Liang, and H. H. Peng, “Melanoma cell extravasation under flow conditions is modulated by leukocytes and endogenously produced interleukin 8,” Mol Cell Biomech, vol. 2, no. 3, pp. 145–159, 2005. View at Google Scholar
  89. T. N. Mayadas, R. C. Johnson, H. Rayburn, R. O. Hynes, and D. D. Wagner, “Leukocyte rolling and extravasation are severely compromised in P selectin–deficient mice,” Cell, vol. 74, no. 3, pp. 541–554, 1993. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Aruffo, M. T. Dietsch, H. Wan, K. E. Hellström, and I. Hellström, “Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma–derived cell lines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 6, pp. 2292–2296, 1992. View at Publisher · View at Google Scholar · View at Scopus
  91. D. J. Goetz, H. Ding, W. J. Atkinson et al., “A human colon carcinoma cell line exhibits adhesive interactions with P- selectin under fluid flow via a PSGL-1-independent mechanism,” American Journal of Pathology, vol. 149, no. 5, pp. 1661–1673, 1996. View at Google Scholar · View at Scopus
  92. S. T. Pottratz, T. D. Hall, W. M. Scribner, H. N. Jayaram, and V. Natarajan, “P-selectin–mediated attachment of small cell lung carcinoma to endothelial cells,” American Journal of Physiology–Lung Cellular and Molecular Physiology, vol. 271, no. 6, pp. L918–L923, 1996. View at Google Scholar · View at Scopus
  93. Y. J. Kim, L. Borsig, N. M. Varki, and A. Varki, “P-selectin deficiency attenuates tumor growth and metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9325–9330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Borsig, R. Wong, R. O. Hynes, N. M. Varki, and A. Varki, “Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non–mucin ligands and implicate leukocytes as enhancers of metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2193–2198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Heidemann, A. Schildt, K. Schmid et al., “Selectins mediate small cell lung cancer systemic metastasis,” PLoS ONE, vol. 9, no. 4, Article ID e92327, 2014. View at Publisher · View at Google Scholar
  96. L. Borsig, “The role of platelet activation in tumor metastasis,” Expert Review of Anticancer Therapy, vol. 8, no. 8, pp. 1247–1255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Karpatkin, E. Pearlstein, C. Ambrogio, and B. S. Coller, “Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo,” Journal of Clinical Investigation, vol. 81, no. 4, pp. 1012–1019, 1988. View at Publisher · View at Google Scholar · View at Scopus
  98. P. S. Kaytes and J.-G. Geng, “P-selectin mediates adhesion of the human melanoma cell line NKI-4: identification of glycoprotein ligands,” Biochemistry, vol. 37, no. 29, pp. 10514–10521, 1998. View at Publisher · View at Google Scholar · View at Scopus
  99. Y.-Q. Ma and J.-G. Geng, “Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow,” Journal of Immunology, vol. 165, no. 1, pp. 558–565, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. Y.-Q. Ma and J.-G. Geng, “Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 cells,” Journal of Immunology, vol. 168, no. 4, pp. 1690–1696, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Li, H. J. Short, K.-X. Qian, A. P. Elhammer, and J.-G. Geng, “Characterization of glycoprotein ligands for P-selectin on a human small cell lung cancer cell line NCI-H345,” Biochemical and Biophysical Research Communications, vol. 288, no. 3, pp. 637–644, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Aigner, Z. M. Sthoeger, M. Fogel et al., “CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells,” Blood, vol. 89, no. 9, pp. 3385–3395, 1997. View at Google Scholar · View at Scopus
  103. B. Nieswandt, M. Hafner, B. Echtenacher, and D. N. Männel, “Lysis of tumor cells by natural killer cells in mice is impeded by platelets,” Cancer Research, vol. 59, no. 6, pp. 1295–1300, 1999. View at Google Scholar · View at Scopus
  104. R. J. Ludwig, B. Boehme, M. Podda et al., “Endothelial P-Selectin as a target of heparin action in experimental melanoma lung metastasis,” Cancer Research, vol. 64, no. 8, pp. 2743–2750, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to virchow?” Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. T. H. Nasti, D. C. Bullard, and N. Yusuf, “P-selectin enhances growth and metastasis of mouse mammary tumors by promoting regulatory T cell infiltration into the tumors,” Life Sciences, vol. 131, pp. 11–18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Schlesinger, M. Roblek, K. Ortmann et al., “The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin,” Thrombosis Research, vol. 133, no. 5, pp. 855–862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Garcia, N. Callewaert, and L. Borsig, “P-selectin mediates metastatic progression through binding to sulfatides on tumor cells,” Glycobiology, vol. 17, no. 2, pp. 185–196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. P. Brodt, L. Fallavollita, R. S. Bresalier, S. Meterissian, C. R. Norton, and B. A. Wolitzky, “Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis,” International Journal of Cancer, vol. 71, no. 4, pp. 612–619, 1997. View at Publisher · View at Google Scholar · View at Scopus
  110. G. Mannori, D. Santoro, L. Carter, C. Corless, R. M. Nelson, and M. P. Bevilacqua, “Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin,” American Journal of Pathology, vol. 151, no. 1, pp. 233–243, 1997. View at Google Scholar · View at Scopus
  111. T. Aychek, K. Miller, O. Sagi-Assif et al., “E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release,” International Journal of Cancer, vol. 123, no. 8, pp. 1741–1750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. P.-L. Tremblay, F. A. Auger, and J. Huot, “Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases,” Oncogene, vol. 25, no. 50, pp. 6563–6573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. M. M. Burdick, J. T. Chu, S. Godar, and R. Sackstein, “HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells,” Journal of Biological Chemistry, vol. 281, no. 20, pp. 13899–13905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Gout, C. Morin, F. Houle, and J. Huot, “Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation,” Cancer Research, vol. 66, no. 18, pp. 9117–9124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Tomlinson, J. L. Wang, S. H. Barsky, M. C. Lee, J. Bischoff, and M. Nguyen, “Human colon cancer cells express multiple glycoprotein ligands for E-selectin,” International Journal of Oncology, vol. 16, no. 2, pp. 347–353, 2000. View at Google Scholar
  116. V. S. Shirure, N. M. Reynolds, and M. M. Burdick, “Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells,” PLoS ONE, vol. 7, no. 9, Article ID e44529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. J. L. Stevenson, A. Varki, and L. Borsig, “Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non–anticoagulant heparins can have additional effects,” Thrombosis Research, vol. 120, no. 2, pp. S107–S111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. K. Park, S. Ki Lee, D. Hyun Son et al., “The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative,” Biomaterials, vol. 28, no. 16, pp. 2667–2676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Hosono, T. Narita, N. Kimura et al., “Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells,” Journal of Surgical Oncology, vol. 67, no. 2, pp. 77–84, 1998. View at Publisher · View at Google Scholar · View at Scopus
  120. O. Insug, L. Otvos Jr., T. Kieber-Emmons, and M. Blaszczyk-Thurin, “Role of SA-Lea and E-selectin in metastasis assessed with peptide antagonist,” Peptides, vol. 23, no. 5, pp. 999–1010, 2002. View at Publisher · View at Google Scholar · View at Scopus
  121. F. Qian, D. Hanahan, and I. L. Weissman, “L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3976–3981, 2001. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Läubli, J. L. Stevenson, A. Varki, N. M. Varki, and L. Borsig, “L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest,” Cancer Research, vol. 66, no. 3, pp. 1536–1542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Yamada, K. Yanaba, M. Hasegawa et al., “Regulation of local and metastatic host–mediated anti–tumour mechanisms by L-selectin and intercellular adhesion molecule-1,” Clinical and Experimental Immunology, vol. 143, no. 2, pp. 216–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Izawa, K. Kumamoto, C. Mitsuoka et al., “Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer,” Cancer Research, vol. 60, no. 5, pp. 1410–1416, 2000. View at Google Scholar · View at Scopus
  125. M. R. Dallas, S.-H. Chen, M. M. Streppel, S. Sharma, A. Maitra, and K. Konstantopoulos, “Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells,” American Journal of Physiology–Cell Physiology, vol. 303, no. 6, pp. C616–C624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  126. R. P. McEver and R. D. Cummings, “Role of PSGL-1 binding to selectins in leukocyte recruitment,” Journal of Clinical Investigation, vol. 100, no. 11, pp. S97–S103, 1997. View at Google Scholar
  127. E. R. Vandendries, B. C. Furie, and B. Furie, “Role of P-selectin and PSGL-I in coagulation and thrombosis,” Thrombosis and Haemostasis, vol. 92, no. 3, pp. 459–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. C. J. Dimitroff, L. Descheny, N. Trujillo et al., “Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells,” Cancer Research, vol. 65, no. 13, pp. 5750–5760, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. L. Gong, Y. Cai, X. Zhou, and H. Yang, “Activated platelets interact with lung cancer cells through P-selectin glycoprotein ligand-1,” Pathology and Oncology Research, vol. 18, no. 4, pp. 989–996, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. G. M. Thomas, L. Panicot-Dubois, R. Lacroix, F. Dignat-George, D. Lombardo, and C. Dubois, “Cancer cell–erived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo,” Journal of Experimental Medicine, vol. 206, no. 9, pp. 1913–1927, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. M. J. C. Hendrix, E. A. Seftor, A. R. Hess, and R. E. B. Seftor, “Vasculogenic mimicry and tumour–cell plasticity: lessons from melanoma,” Nature Reviews Cancer, vol. 3, no. 6, pp. 411–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Tímár, J. Tóvári, E. Rásó, L. Mészáros, B. Bereczky, and K. Lapis, “Platelet–mimicry of cancer cells: epiphenomenon with clinical significance,” Oncology, vol. 69, no. 3, pp. 185–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Trikha, J. Timar, S. K. Lundy et al., “The high affinity αIIbβ3 integrin is involved in invasion of human melanoma cells,” Cancer Research, vol. 57, no. 12, pp. 2522–2528, 1997. View at Google Scholar · View at Scopus
  134. C. Tellez, M. McCarty, M. Ruiz, and M. Bar-Eli, “Loss of activator protein-2α results in overexpression of protease–activated receptor-1 and correlates with the malignant phenotype of human melanoma,” Journal of Biological Chemistry, vol. 278, no. 47, pp. 46632–46642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  135. T. Iwamura, T. C. Caffrey, N. Kitamura, H. Yamanari, T. Setoguchi, and M. A. Hollingsworth, “P-selectin expression in a metastatic pancreatic tumor cell line (SUIT- 2),” Cancer Research, vol. 57, no. 6, pp. 1206–1212, 1997. View at Google Scholar · View at Scopus
  136. A. Treszl, A. Ladanyi, Z. Rakosy, Z. Buczko, R. Adany, and M. Balazs, “Molecular cytogenetic characterization of a novel cell line established from a superficial spreading melanoma,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1844–1853, 2006. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Xia, M. Sperandio, T. Yago et al., “P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow,” Journal of Clinical Investigation, vol. 109, no. 7, pp. 939–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. D. S. Krause, K. Lazarides, J. B. Lewis, U. H. Von Andrian, and R. A. Van Etten, “Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche,” Blood, vol. 123, no. 9, pp. 1361–1371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Ponnusamy, N. Kohrs, A. Ptasinska et al., “RUNX1/ETO blocks selectin–mediated adhesion via epigenetic silencing of PSGL-1,” Oncogenesis, vol. 4, e146 pages, 2015. View at Publisher · View at Google Scholar
  140. J. Kappelmayer, A. Kiss, É. Karászi, A. Veszprémi, J. Jakó, and C. Kiss, “Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias,” British Journal of Haematology, vol. 115, no. 4, pp. 903–909, 2001. View at Publisher · View at Google Scholar · View at Scopus
  141. A. K. Azab, P. Quang, F. Azab et al., “P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment,” Blood, vol. 119, no. 6, pp. 1468–1478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. K. Miszti-Blasius, S. Felszeghy, C. Kiss et al., “P-selectin glycoprotein ligand-1 deficiency augments G-CSF induced myeloid cell mobilization,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 387, no. 2, pp. 109–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. G. Raes, G. H. Ghassabeh, L. Brys et al., “The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas,” International Journal of Cancer, vol. 121, no. 12, pp. 2646–2652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. P. Li, M. Li, M. R. Lindberg, M. J. Kennett, N. Xiong, and Y. Wang, “PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps,” The Journal of Experimental Medicine, vol. 207, no. 9, pp. 1853–1862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  146. T. A. Fuchs, A. Brill, D. Duerschmied et al., “Extracellular DNA traps promote thrombosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15880–15885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. K. Kambas, I. Mitroulis, and K. Ritis, “The emerging role of neutrophils in thrombosis–he journey of TF through NETs,” Frontiers in Immunology, vol. 3, Article ID Article 385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Caudrillier, K. Kessenbrock, B. M. Gilliss et al., “Platelets induce neutrophil extracellular traps in transfusion–related acute lung injury,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2661–2671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  149. M. Demers and D. D. Wagner, “Neutrophil extracellular traps: a new link to cancer–associated thrombosis and potential implications for tumor progression,” OncoImmunology, vol. 2, no. 2, Article ID e22946, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Demers and D. D. Wagner, “NETosis: a new factor in tumor progression and cancer–associated thrombosis,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 3, pp. 277–283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. M. Demers, D. S. Krause, D. Schatzberg et al., “Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer–associated thrombosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 32, pp. 13076–13081, 2012. View at Publisher · View at Google Scholar · View at Scopus
  152. C. Thålin, M. Demers, B. Blomgren et al., “NETosis promotes cancer–associated arterial microthrombosis presenting as ischemic stroke with troponin elevation,” Thrombosis Research, vol. 139, pp. 56–64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  153. J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner, and D. D. Wagner, “P-selectin promotes neutrophil extracellular trap formation in mice,” Blood, vol. 126, no. 2, pp. 242–246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  154. J. Puegge, Y. Wang, J. Roller et al., “Adhesive mechanisms of histone–induced neutrophil–endothelium interactions in the muscle microcirculation,” European Surgical Research, vol. 56, no. 1-2, pp. 19–31, 2016. View at Publisher · View at Google Scholar · View at Scopus
  155. M. Wahrenbrock, L. Borsig, D. Le, N. Varki, and A. Varki, “Selectin–mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas,” Journal of Clinical Investigation, vol. 112, no. 6, pp. 853–862, 2003. View at Publisher · View at Google Scholar · View at Scopus
  156. B. Shao, M. G. Wahrenbrock, L. Yao et al., “Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome,” Blood, vol. 118, no. 15, pp. 4015–4023, 2011. View at Publisher · View at Google Scholar · View at Scopus
  157. D. Ansari, R. Andersson, and A. Andrén-Sandberg, “Pancreatic cancer and thromboembolic disease, 150 years after Trousseau,” Hepatobiliary Surgery and Nutrition, vol. 4, no. 5, pp. 325–335, 2015. View at Google Scholar